- Home
- NDLS vs SERA Comparison
NDLS vs SERA Comparison
Compare NDLS & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NDLS | SERA |
|---|---|---|
| Founded | 1995 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.7M | 75.2M |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NDLS | SERA |
|---|---|---|
| Price | $12.33 | $1.68 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 59.2K | 36.5K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.32 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $495,089,000.00 | $81,000.00 |
| Revenue This Year | N/A | $554.81 |
| Revenue Next Year | N/A | $517.27 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 0.37 | ★ 5.19 |
| 52 Week Low | $0.47 | $1.37 |
| 52 Week High | $13.95 | $4.09 |
Technical Indicators
Market Signals| Indicator | NDLS | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 62.93 | 42.21 |
| Support Level | $0.60 | N/A |
| Resistance Level | $13.95 | $2.41 |
| Average True Range (ATR) | 1.08 | 0.22 |
| MACD | -0.12 | -0.02 |
| Stochastic Oscillator | 53.77 | 33.90 |
Price Performance
Historical ComparisonAbout NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services. It is focused on offering customers flavorful, cooked-to-order dishes in a warm and welcoming environment at an attractive value. It has approximately 340 company-owned restaurants and 83 franchise restaurants in 31 states.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.